Ronald de Wit
Department of Medical Oncology
Rotterdam Cancer Institute (Daniel den Hoed Kliniek)
University Hospital Rotterdam
P.O. Box 5201
Netherlands
Name/email consistency: high
- Overview of gemcitabine triplets in metastatic bladder cancer. de Wit, R., Bellmunt, J. Crit. Rev. Oncol. Hematol. (2003)
- Overview of bladder cancer trials in the European Organization for Research and Treatment. de Wit, R. Cancer (2003)
- Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. de Wit, R., Roberts, J.T., Wilkinson, P.M., de Mulder, P.H., Mead, G.M., Fosså, S.D., Cook, P., de Prijck, L., Stenning, S., Collette, L. J. Clin. Oncol. (2001)